The cause is said to be a “product mix up,” as a drug meant to treat a different condition was reportedly discovered.

Tirzepatide outperformed semaglutide in simultaneously achieving four key therapeutic targets for type 2 diabetes.

The revised medication list for blood pressure management was: sacubitril valsartan sodium tablets (100 mg, twice daily), metoprolol tartrate tablets (25 mg, twice daily), amlodipine besylate tablets ...

Granules India receives U.S. FDA approval for Losartan and Hydrochlorothiazide Tablets USP, indicated to lower blood pressure and reduce stroke risk. Annual U.S. market for product estimated at ...

Losartan potassium tablets are indicated for the treatment of hypertension in adults and paediatric patients — six years of age and older — to lower blood pressure ...

Ahmedabad: Zydus Lifesciences Limited (formerly known as Cadila Healthcare Limited) has received final approval from the United States Food and Drug Administration (USFDA) to market Bisoprolol ...

Zydus Lifesciences has received final approval from the United States Food and Drug Administration (USFDA) to market Bisoprolol Fumarate and Hydrochlorothiazide tablets USP, 2.5 mg/6.25 mg, 5 mg/6.25 ...

Two lots of quinapril and hydrochlorothiazide tablets have been recalled due to the presence of nitrosamines.